EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Anticancer efficacy of bis-heteroleptic iridium( iii ) complexes with difluoro-substituted phenylpyridine ligands

Suvasmita Behera, Kahnu Charan Pradhan iD, Sahadev Barik, Moloy Sarkar, Jagadish Kumar iD, Jagneshwar Dandapat, Jyotsnarani Pradhan, Satyanarayan Pal iD

RSC Advances · 2025 · 15 (28) · 22875-22888

DOI: 10.1039/d5ra03076e ↗

Kurz gefasst

Fachartikel in der Zeitschrift RSC Advances, 2025. Verfasst von Suvasmita Behera und 7 weiteren Autor:innen. Beteiligte Einrichtung: P.G. Dept. of Chemistry, Utkal University Bhubaneswar Odisha 751004 India snpal@utkaluniversity.ac.in. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Three cyclometallated Ir( iii ) complexes made of 2-(2,4-difluorophenyl)pyridine (F 2 ppy), along with pyridine-2-aldoxime and its two derivatives, were prepared and explored as anticancer agents against MDAMB, HT-29 and LN-229 cell lines.

Autor:innen und Institutionen

  • P.G. Dept. of Chemistry, Utkal University Bhubaneswar Odisha 751004 India snpal@utkaluniversity.ac.in.
  • Centre of Excellence in Advanced Materials and Applications, Utkal University Bhubaneswar Odisha 751004 India.
  • School of Chemical Sciences, National Institute of Science Education and Research Bhubaneswar Odisha 752050 India.
  • Dept. of Physics, Utkal University Bhubaneswar Odisha 751004 India.
  • Dept. of Biotechnology, Utkal University Bhubaneswar Odisha 751004 India.

ORCID-Profile: Kahnu Charan Pradhan, Jagadish Kumar, Satyanarayan Pal

Zitieren

APA

Behera, S., Pradhan, K. C., Barik, S., Sarkar, M., Kumar, J., Dandapat, J., Pradhan, J., & Pal, S. (2025). Anticancer efficacy of bis-heteroleptic iridium( iii ) complexes with difluoro-substituted phenylpyridine ligands. RSC Advances, 15(28), 22875-22888. https://doi.org/10.1039/d5ra03076e

Vancouver

Behera S, Pradhan KC, Barik S, Sarkar M, Kumar J, Dandapat J, et al. Anticancer efficacy of bis-heteroleptic iridium( iii ) complexes with difluoro-substituted phenylpyridine ligands. RSC Advances. 2025;15(28):22875-22888. doi:10.1039/d5ra03076e

BibTeX
@article{Behera2025,
  author = {Behera, Suvasmita and Pradhan, Kahnu Charan and Barik, Sahadev and Sarkar, Moloy and Kumar, Jagadish and Dandapat, Jagneshwar and Pradhan, Jyotsnarani and Pal, Satyanarayan},
  title = {Anticancer efficacy of bis-heteroleptic iridium( iii ) complexes with difluoro-substituted phenylpyridine ligands},
  journal = {RSC Advances},
  year = {2025},
  volume = {15},
  number = {28},
  pages = {22875--22888},
  doi = {10.1039/d5ra03076e}
}
Kostenlos starten →